Ucb Biopharma Srl

This study tests a drug called bimekizumab in children and teenagers (ages 9 to 17) with moderate to severe hidradenitis suppurativa, a painful skin condition that causes boils. The goal is to see how the drug works in the body and if it is safe. About 40 participants will receiv…

This study tests the drug rozanolixizumab in 40 Chinese adults with generalized myasthenia gravis, a condition that causes muscle weakness. The main goal is to see if the drug improves daily activities after one treatment cycle. Participants receive the drug and are monitored for…

This study looks at the long-term safety of the drug brivaracetam in about 120 children and teens with childhood or juvenile absence epilepsy. Participants will take the medication and be monitored for side effects over time. The goal is to see if the drug is safe to use for ongo…

This study tests a new medicine called galvokimig for adults with moderate-to-severe atopic dermatitis (eczema). About 160 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness and itching. The main goal is to find the best dose t…

This study compares two injectable drugs, bimekizumab and ustekinumab, in children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab is more effective at clearing skin lesions. Participants will receive either drug for several week…

This study tests an experimental drug called rozanolixizumab in 12 children aged 2 to 17 with moderate to severe generalized myasthenia gravis, a condition that causes muscle weakness. The drug is given as an injection under the skin to see if it is safe and tolerable. The study …

This study is testing whether giving bimekizumab through an IV (drip) works as well as the usual shot under the skin for people with active psoriatic arthritis or axial spondyloarthritis. About 392 adults who are suitable for bimekizumab treatment will take part. The main goal is…

This study tests whether adding dapirolizumab pegol to standard lupus treatments can better control moderate-to-severe lupus symptoms over 48 weeks. About 450 adults with active lupus will receive either the drug or a placebo. The goal is to see if the drug reduces disease activi…

This study tests a drug called bimekizumab in 40 children aged 2 to 17 with certain types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). The main goal is to see how the drug moves through the body and to check for side effects. Participants…

This study tests a drug called bimekizumab against a placebo in 300 adults with palmoplantar pustulosis, a condition causing painful blisters on the palms and soles. The goal is to see if the drug can clear or nearly clear the skin lesions within 16 weeks. Participants will be ra…

This study tests a new inhaled medicine, Staccato alprazolam, to see if it can stop a prolonged seizure within 90 seconds and prevent another seizure for at least 2 hours. About 350 people aged 12 and older with stereotypical prolonged seizures will take part. The medicine is com…

This study looks at how much of the drug bimekizumab passes into breast milk. It involves 20 breastfeeding mothers with conditions like psoriasis or arthritis who are already taking the drug. Researchers will collect milk samples over several days to measure drug levels and estim…

This study looks at how much of the drug zilucoplan and its breakdown products end up in the breast milk of healthy women who are breastfeeding. About 15 women who are at least 6 weeks postpartum and already planning to stop breastfeeding will take the drug daily for a short time…